Amdocs Résultats passés
Passé contrôle des critères 3/6
Les bénéfices de Amdocs ont diminué à un taux annuel moyen de -4.5%, tandis que le secteur IT a vu ses bénéfices augmenter de en à 9.3% par an. Les revenus ont augmenté de en à un taux moyen de 2.6% par an. Le rendement des capitaux propres de Amdocs est 16.6% et ses marges nettes sont de 12.5%.
Informations clés
-4.47%
Taux de croissance des bénéfices
-0.69%
Taux de croissance du BPA
| IT Croissance de l'industrie | 22.43% |
| Taux de croissance des recettes | 2.60% |
| Rendement des fonds propres | 16.58% |
| Marge nette | 12.47% |
| Prochaine mise à jour des résultats | 13 May 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour de l'analyse • Apr 26
DOX: Future EPS Guidance And Buybacks Will Support Multiple Rerating
Analysts have trimmed their Amdocs fair value estimate by about $0.36 to $90.21, reflecting updated assumptions around discount rates, long term revenue growth, profit margins, and future P/E expectations following recent price target reductions from major firms. Analyst Commentary Recent research updates have focused less on headline ratings and more on recalibrating what investors might reasonably pay for Amdocs, with both price targets moving lower and feeding into the modest trim to the fair value estimate.Seeking Alpha • Apr 16
Amdocs Shows Strong Cash Flow At A Cheap Price
Summary Amdocs is rated a Buy, offering strong free cash flow, resilient fundamentals, and attractive valuation near 52-week lows. DOX boasts a $4.25B backlog, robust managed services, and recent acquisitions (MATRIXX, Profinit) driving half of projected 2026 revenue growth. Free cash flow yield stands at 10%, with 90% earnings conversion, a rising 3.5% dividend, and $840M in buyback authorization through 2025. Risks include telecom IT spending cuts, GenAI adoption uncertainty, and T-Mobile concentration, but long-term contracts and a solid balance sheet provide downside protection. Read the full article on Seeking AlphaMise à jour de l'analyse • Apr 06
DOX: Reset Guidance And Shareholder Returns Will Support Multiple Rerating
Analysts have trimmed their average price target on Amdocs by $19 to $90.57, citing updated assumptions around discount rates, long term growth, margins and future P/E multiples reflected in recent research from major firms. Analyst Commentary Recent research updates suggest that analysts are recalibrating their views on Amdocs, with price targets being reset to reflect revised assumptions around growth, profitability and valuation multiples.
Nouvelle analyse • Mar 31
Cloud Migration And AI Adoption Will Shape Telecom Software Returns By 2029
Catalysts About Amdocs Amdocs provides software, services and managed solutions that support telecom operators in areas such as billing, customer experience, network operations and data driven applications. What are the underlying business or industry changes driving this perspective?Mise à jour de l'analyse • Mar 22
DOX: Reset Guidance And Capital Returns Will Support Multiple Rerating
Analysts have trimmed their Amdocs fair value estimate by about $3.25 to $90.57, citing slightly softer revenue growth and profit margin assumptions, partly offset by a higher forward P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts point to the maintained use of a higher forward P/E multiple in fair value work, which suggests ongoing confidence in Amdocs' earnings quality and pricing power, even with more conservative revenue and margin inputs.
Nouvelle analyse • Mar 17
Cloud And AI Transformation Will Reshape Telecom Operations Over The Next Decade
Catalysts About Amdocs Amdocs provides software, services and managed solutions that support mission critical business and operations systems for telecom and media companies worldwide. What are the underlying business or industry changes driving this perspective?Mise à jour de l'analyse • Mar 07
DOX: Reset Guidance And Capital Returns Will Support Future Repricing
Analysts have reduced their Amdocs price targets by roughly $10 to $20, citing updated assumptions around discount rates and future P/E, while maintaining a broadly unchanged view of the stock’s fair value. Analyst Commentary Recent research updates keep the core investment view on Amdocs largely intact, even as price targets are reset to reflect revised discount rates and updated P/E assumptions.Mise à jour de l'analyse • Feb 21
DOX: Reset Guidance And Shareholder Returns Will Support Future Earnings Rebound
Analysts have reduced their price targets for Amdocs by $19 and $9, citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E as the main reasons for the adjustment. Analyst Commentary Recent target cuts suggest analysts are reassessing how they value Amdocs, focusing on what they see as more conservative assumptions for fair value, discount rates, revenue growth, profit margins and future P/E levels.Mise à jour de l'analyse • Feb 06
DOX: Reset FY26 Guidance And Buybacks Will Support Earnings Rebound
Narrative Update Analysts have trimmed their price target on Amdocs to about $95.50 from roughly $104, citing constraints on growth, lower FY26 revenue and EPS guidance versus prior Street expectations, and a revised view on margins and future P/E multiples. Analyst Commentary Recent research updates on Amdocs point to a more cautious stance, with multiple firms trimming price targets and highlighting a gap between company guidance and prior Street expectations.Article d'analyse • Jan 14
Is Amdocs Limited (NASDAQ:DOX) Trading At A 36% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Amdocs fair value estimate is US$130 Amdocs is estimated to be...Article d'analyse • Jul 30
Amdocs Limited's (NASDAQ:DOX) Intrinsic Value Is Potentially 76% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Amdocs fair value estimate is US$153 Current share price of...Article d'analyse • Jul 12
Here's Why Amdocs (NASDAQ:DOX) Can Manage Its Debt Responsibly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Article d'analyse • Jun 24
Amdocs (NASDAQ:DOX) Might Have The Makings Of A Multi-Bagger
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...Article d'analyse • May 15
We Think Amdocs' (NASDAQ:DOX) Solid Earnings Are Understated
Amdocs Limited's ( NASDAQ:DOX ) solid earnings announcement recently didn't do much to the stock price. We did some...Article d'analyse • May 13
Amdocs (NASDAQ:DOX) Is Due To Pay A Dividend Of $0.527
Amdocs Limited ( NASDAQ:DOX ) will pay a dividend of $0.527 on the 25th of July. The payment will take the dividend...Seeking Alpha • Apr 25
Amdocs Exits Low-Margin Activities But Growth Remains Uncertain
Summary Amdocs has made recent moves to exit low-margin business activities to improve its focus and profitability. However, the company is still working to improve revenue growth despite macroeconomic uncertainties in international markets as a result of recent tariff policy changes. Given the firm’s low growth rate on higher gross margin and an indication the stock may be overvalued on a DCF basis, my outlook on DOX remains a neutral Hold. Read the full article on Seeking AlphaSeeking Alpha • Feb 07
Amdocs: Focused On Improving Margins
Summary Today, we take a look at Amdocs Limited, which posted quarterly earnings this week and boosted its dividend payouts by 10%. The company is focused on phasing out low-margin businesses to continue to boost operating margins. This is resulting in significant free cash flow for the company. An analysis of Amdocs Limited follows in the paragraphs below. Read the full article on Seeking Alpha
Nouvelle analyse • Aug 25
Cloud Innovation And AI Partnerships Propel Revenue And Margins Skyward
Strategic focus on cloud migration, AI investments, and partnerships for innovation promises efficiency gains and new revenue streams, enhancing net margins.Seeking Alpha • Aug 23
Amdocs Growth Remains Anemic On Client Buying Scrutiny
Summary Amdocs recently reported its FQ3 2024 results, meeting revenue estimates but beating earnings expectations. The market outlook for customer experience management is positive, with Amdocs active in various business software vertical markets. Financial trends show slow revenue growth, declining earnings per share, and reduced operating margin. I remain Neutral (Hold) on DOX until management can convert its strong backlog into revenue growth. Read the full article on Seeking AlphaSeeking Alpha • Jun 07
Amdocs: An Undervalued Dividend Growth Stock With 28% Margin Of Safety
Summary Amdocs Limited is an undervalued dividend-growth company with a low debt-to-capital ratio and expected high single-digit earnings growth. The company is a leading provider of software and services for communications and media industry providers. Amdocs has a strong balance sheet and predictable revenue, and analysts are bullish on its future prospects. It is a dividend growth stock, having raised dividends at an average of 12.59% for the past 12 years. Amdocs Limited stock is well-priced with a 28% margin of safety and an upside potential of 17.55%. Read the full article on Seeking AlphaSeeking Alpha • Apr 16
Amdocs: Financial Prospects And Capital Return Are Key Investment Considerations
Summary Amdocs' upcoming second quarter results could miss the market's expectations, if a bigger-than-expected reduction in telecommunications companies' spending on legacy systems materializes. DOX boasts an appealing high single digit percentage forward shareholder yield on the assumption that the company will continue to distribute most of its free cash flow to its shareholders. A Hold rating for Amdocs is justified, taking into account both its financial outlook and shareholder capital return approach. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Amdocs gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 25 | 4,579 | 571 | 498 | 338 |
| 30 Sep 25 | 4,533 | 565 | 506 | 341 |
| 30 Jun 25 | 4,647 | 558 | 523 | 343 |
| 31 Mar 25 | 4,752 | 544 | 539 | 347 |
| 31 Dec 24 | 4,870 | 499 | 552 | 356 |
| 30 Sep 24 | 5,005 | 493 | 573 | 361 |
| 30 Jun 24 | 4,984 | 509 | 575 | 368 |
| 31 Mar 24 | 4,970 | 528 | 574 | 370 |
| 31 Dec 23 | 4,947 | 556 | 570 | 368 |
| 30 Sep 23 | 4,888 | 541 | 571 | 375 |
| 30 Jun 23 | 4,811 | 568 | 560 | 373 |
| 31 Mar 23 | 4,736 | 537 | 552 | 371 |
| 31 Dec 22 | 4,658 | 546 | 544 | 368 |
| 30 Sep 22 | 4,577 | 550 | 529 | 355 |
| 30 Jun 22 | 4,498 | 544 | 525 | 340 |
| 31 Mar 22 | 4,403 | 562 | 511 | 331 |
| 31 Dec 21 | 4,307 | 522 | 493 | 319 |
| 30 Sep 21 | 4,289 | 688 | 487 | 313 |
| 30 Jun 21 | 4,254 | 699 | 468 | 307 |
| 31 Mar 21 | 4,214 | 674 | 455 | 297 |
| 31 Dec 20 | 4,213 | 682 | 457 | 290 |
| 30 Sep 20 | 4,169 | 498 | 459 | 282 |
| 30 Jun 20 | 4,146 | 485 | 477 | 276 |
| 31 Mar 20 | 4,145 | 496 | 493 | 275 |
| 31 Dec 19 | 4,117 | 494 | 494 | 273 |
| 30 Sep 19 | 4,087 | 479 | 492 | 274 |
| 30 Jun 19 | 4,059 | 402 | 493 | 275 |
| 31 Mar 19 | 4,036 | 362 | 485 | 279 |
| 31 Dec 18 | 4,009 | 339 | 484 | 277 |
| 30 Sep 18 | 3,975 | 354 | 481 | 277 |
| 30 Jun 18 | 3,952 | 417 | 476 | 271 |
| 31 Mar 18 | 3,916 | 445 | 473 | 265 |
| 31 Dec 17 | 3,890 | 456 | 467 | 267 |
| 30 Sep 17 | 3,867 | 437 | 473 | 259 |
| 30 Jun 17 | 3,828 | 425 | 470 | 255 |
| 31 Mar 17 | 3,792 | 411 | 469 | 253 |
| 31 Dec 16 | 3,751 | 406 | 469 | 250 |
| 30 Sep 16 | 3,718 | 409 | 465 | 252 |
| 30 Jun 16 | 3,704 | 405 | 459 | 257 |
| 31 Mar 16 | 3,682 | 407 | 453 | 255 |
| 31 Dec 15 | 3,659 | 416 | 446 | 254 |
| 30 Sep 15 | 3,644 | 446 | 440 | 255 |
| 30 Jun 15 | 3,617 | 456 | 439 | 257 |
Des revenus de qualité: DOX a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de DOX sont plus élevées que l'année dernière DOX. (12.5%) sont plus élevées que l'année dernière (10.2%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de DOX ont diminué de 4.5% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de DOX au cours de l'année écoulée ( 14.4% ) dépasse sa moyenne sur 5 ans ( -4.5% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices DOX au cours de l'année écoulée ( 14.4% ) n'a pas surpassé celle du secteur IT 32.1%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de DOX ( 16.6% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/06 06:04 |
| Cours de l'action en fin de journée | 2026/05/06 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/09/30 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Amdocs Limited est couverte par 24 analystes. 5 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Amir Rozwadowski | Barclays |
| Tavy Rosner | Barclays |
| Tal Liani | BofA Global Research |